Firefly's Blue Ghost lander achieved a historic milestone, becoming the second private company to accomplish a soft lunar landing, as part of NASA's CLPS and Artemis programs, paving the way for future human exploration of the moon.
SIGGRAPH, a leading computer graphics organization, drives innovation through global conferences like SIGGRAPH 2025 in Vancouver and SIGGRAPH Asia 2025 in Hong Kong, while also addressing community concerns, recognizing outstanding service, and exploring cutting-edge topics like hybrid physical AI and digital twins.
In a major global outage, Microsoft left tens of thousands of users in major cities like New York, Chicago, and Los Angeles unable to access email and apps like Outlook, Exchange, Teams, and Azure for several hours before resolving the issue without specifying the cause.
Intel's highly anticipated $20 billion semiconductor manufacturing plant in Ohio faces a significant setback, with the company announcing a delay in the facility's launch and production start until 2030 or 2031, citing the need to align with market demand and business requirements.
Rare diseases affect millions but face an uphill battle for diagnosis, treatment, and research due to their rarity, despite efforts like federal incentives and patient advocacy, underscoring the need for increased focus to unlock medical insights and cures.
The Fear & Greed Index, which measures investor sentiment based on factors like market momentum and volatility, currently stands at 61 out of 100, signaling that greed is fueling the US stock market's movements and potentially overvaluing stocks.
After over a decade of neglect, Microsoft is finally retiring the once-popular Skype messaging service on May 5, 2025, urging users to migrate to its Teams platform instead, as Skype struggles to keep up with rivals like Telegram, WhatsApp, and Discord.
DOGE alleges wasteful government software license surplus, but experts contextualize reasons like bundled purchases and future staffing needs, highlighting nuance beyond DOGE's criticism.
OpenAI, after hitting scaling limits with its GPT models, is pivoting its core AI strategy, shifting from building larger models to a hybrid approach combining pre-training and 'chain of thought' reasoning techniques, with potential industry-wide implications.
ReviveMed unveiled an AI-powered metabolomics platform with mzLearn algorithm for automated metabolite detection, enabling pre-trained generative AI models that outperformed clinical risk scores in predicting renal cell carcinoma outcomes, paving the way for precision medicine breakthroughs.